Protein kinase inhibitors
作者： Alexander Levitzki
DOI: 10.1016/B978-0-12-374145-5.00065-6
关键词: Diabetes mellitus 、 Biochemistry 、 Drug 、 Biology 、 Protein kinase B 、 Hemorrhagic shock 、 Isoquinoline 、 Pharmacology 、 Protein kinase A 、 Kinase
摘要: Novel isoquinoline derivatives which are useful as inhibitors of protein kinases for experimental, medical, and drug design purposes disclosed. Preferred compounds specific kinase B also Furthermore, pharmaceutical compositions comprising these inhibitors, methods using such treatment diagnosis cancers, diabetes, cardiovascular pathologies, hemorrhagic shock, obesity, inflammatory diseases, diseases the central nervous system, autoimmune
elsevier.com
lens.org 参考文章(111)
K.K. Roy, E.A. Sausville, Early Development of Cyclin Dependent Kinase Modulators Current Pharmaceutical Design. ,vol. 7, pp. 1669- 1687 ,(2001) , 10.2174/1381612013397230
Norman P, OSI-774 OSI Pharmaceuticals. Current opinion in investigational drugs. ,vol. 2, pp. 298- 304 ,(2001)
Judith S. Sebolt-Leopold, David T. Dudley, Roman Herrera, Keri Van Becelaere, Amy Wiland, Richard C. Gowan, Haile Tecle, Stephen D. Barrett, Alexander Bridges, Sally Przybranowski, W.R. Leopold, Alan R. Saltiel, Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nature Medicine. ,vol. 5, pp. 810- 816 ,(1999) , 10.1038/10533
Adrian M. Senderowicz, Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. Investigational New Drugs. ,vol. 17, pp. 313- 320 ,(1999) , 10.1023/A:1006353008903
N. Osherov, A. Gazit, C. Gilon, A. Levitzki, Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins Journal of Biological Chemistry. ,vol. 268, pp. 11134- 11142 ,(1993) , 10.1016/S0021-9258(18)82102-0
M Anafi, A Gazit, C Gilon, Y Ben-Neriah, A Levitzki, Selective interactions of transforming and normal abl proteins with ATP, tyrosine-copolymer substrates, and tyrphostins. Journal of Biological Chemistry. ,vol. 267, pp. 4518- 4523 ,(1992) , 10.1016/S0021-9258(18)42864-5
Alexander Levitzki, Chun-Ming Tsai, Aviv Gazit, Chia-Chien Cheng, Li-Hwa Wu, Kuo-Ting Chang, Reury-Perng Perng, Enhancement of Chemosensitivity by Tyrphostin AG825 in High-p185neu Expressing Non-Small Cell Lung Cancer Cells Cancer Research. ,vol. 56, pp. 1068- 1074 ,(1996)
Alexander Levitzki, Signal-transduction therapy FEBS Journal. ,vol. 226, pp. 1- 13 ,(1994) , 10.1111/J.1432-1033.1994.000T1.X
Walter H.J. Ward, Peter N. Cook, Anthony M. Slater, D.Huw Davies, Geoffrey A. Holdgate, Leslie R'. Green, Epidermal growth factor receptor tyrosine kinase: Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor Biochemical Pharmacology. ,vol. 48, pp. 659- 666 ,(1994) , 10.1016/0006-2952(94)90042-6
Alexander Levitzki, Rubina Levitzki, Zippora Shlomai, Nurit Kleinberger-Doron, Aviv Gazit, Gregory Plowman, Zippora Hartzstark, Hannah Ben-Bassat, Stella Rosenbaum-Mitrani, Rimona Tsvieli, Inhibitors of Epidermal Growth Factor Receptor Kinase and of Cyclin-dependent Kinase 2 Activation Induce Growth Arrest, Differentiation, and Apoptosis of Human Papilloma Virus 16-immortalized Human Keratinocytes Cancer Research. ,vol. 57, pp. 3741- 3750 ,(1997)